Emily R. Whelan

1.9k citations
7 papers · 50 indexed · h-index 4
Topics
Connective tissue disorders research (3 papers)Peptidase Inhibition and Analysis (2 papers)Pancreatic and Hepatic Oncology Research (1 paper)
Partner nations
United StatesCanada

In The Last Decade

Emily R. Whelan

6 papers receiving 50 citations

Peers

Emily R. Whelan
Comparison fields: 5 of 26
  • Oncology 23
  • Molecular Biology 20
  • Cancer Research 14
  • Genetics 12
  • Cardiology and Cardiovascular Medicine 9
Replace Émilie Angot with:
Émilie Angot France
Kuang Lin United Kingdom
Hisaya Kato Japan
Nilofer Azad United States
Lisa Buci Italy
Xiao Bao China
Priscila Muñoz-Sandoval United States
P Badea Romania
Alisha Chou United States
Lindsey Beffa United States
Emily R. Whelan relative to Émilie Angot France Émilie Angot's profile →
Citations per field
00.5×4.5×
Émilie Angot · 1×
Citations per year

Countries citing papers authored by Emily R. Whelan

Since Specialization
Citations

This map shows the geographic impact of Emily R. Whelan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily R. Whelan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily R. Whelan more than expected).

Fields of papers citing papers by Emily R. Whelan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily R. Whelan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily R. Whelan. The network helps show where Emily R. Whelan may publish in the future.

Co-authorship network of co-authors of Emily R. Whelan

This figure shows the co-authorship network connecting the top 25 collaborators of Emily R. Whelan. A scholar is included among the top collaborators of Emily R. Whelan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily R. Whelan. Emily R. Whelan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 2
2 2
3 0
4 8
5 6
6 6
7 26

About Emily R. Whelan

Emily R. Whelan is a scholar working on Speech and Hearing, Small Animals and Cardiology and Cardiovascular Medicine, having authored 7 papers that have together received 50 indexed citations. Recurring topics across this work include Connective tissue disorders research (3 papers), Peptidase Inhibition and Analysis (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Cancer Research (14 citations), Oncology (23 citations) and Rheumatology (7 citations). Emily R. Whelan has collaborated with scholars based in United States and Canada. Frequent co-authors include John D. McPherson, Treasa A. McPherson, Spring Holter, Robert C. Grant, Zaheer Kanji, Vanya Peltekova, Wigdan Al-Sukhni, Katelyn A. Bruno, Ayelet Borgida and Stefano Serra. Their work appears in journals such as International Journal of Molecular Sciences, The Laryngoscope and Journal of Clinical Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026